Naproxen/Caffeine

萘普生/咖啡因

Report date: 2022/08/04 20:00:29

Base Information

Drug NameNaproxen/Caffeine
Drug Alias NameCaffeine/naproxen sodium - BayerBAY-2880376
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsAdenosine A1 receptor antagonistsAdenosine A2a receptor antagonists
TargetsAdenosine A1 receptorAdenosine A2a receptorCyclooxygenases
Therapy Area/IndicationsPain, Postoperative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes NaproxenCaffeine
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesBayer AG
Inactive CompaniesN/A
Active IndicationsPain, Postoperative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A